Schrodinger, Inc. (NASDAQ:SDGR – Get Free Report) CFO Rachit Jain sold 1,631 shares of the firm’s stock in a transaction that occurred on Thursday, March 5th. The shares were sold at an average price of $12.90, for a total transaction of $21,039.90. Following the completion of the transaction, the chief financial officer directly owned 52,596 shares in the company, valued at approximately $678,488.40. The trade was a 3.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Schrodinger Stock Performance
SDGR opened at $12.74 on Monday. The company has a fifty day moving average price of $14.77 and a two-hundred day moving average price of $17.57. The firm has a market capitalization of $938.49 million, a PE ratio of -8.97 and a beta of 1.57. Schrodinger, Inc. has a 52 week low of $11.11 and a 52 week high of $27.63.
Schrodinger (NASDAQ:SDGR – Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.57. Schrodinger had a negative return on equity of 29.47% and a negative net margin of 40.37%.The company had revenue of $87.24 million for the quarter, compared to the consensus estimate of $83.66 million. During the same quarter in the prior year, the business posted ($0.24) EPS. The firm’s quarterly revenue was up 4.7% on a year-over-year basis. Equities analysts forecast that Schrodinger, Inc. will post -2.37 EPS for the current year.
Institutional Inflows and Outflows
Schrodinger News Summary
Here are the key news stories impacting Schrodinger this week:
- Positive Sentiment: Yahoo Finance piece highlights an evolving investment thesis as Schrödinger shifts toward hosted software and resets targets, which could support longer-term sentiment if adoption and ARR trajectory improve. How The Schrödinger (SDGR) Investment Story Is Evolving With Hosted Software And Reset Targets
- Neutral Sentiment: Transcript from Schrödinger’s TD Cowen conference presentation provides management commentary and detail that investors can use to re-assess guidance, product roadmap and commercialization progress; useful but not an immediate catalyst. Schrödinger, Inc. (SDGR) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Negative Sentiment: CEO Ramy Farid sold 3,661 shares at an average $12.91 (?1.09% reduction in his stake), a high-profile insider sale that can signal near-term selling pressure. CEO Form 4
- Negative Sentiment: CFO Rachit Jain sold 1,631 shares at ~$12.90 (?3.01% reduction), adding to the cluster of exec sales that market participants often interpret as a negative signal. CFO Form 4
- Negative Sentiment: Other senior leaders (EVPs Kenneth Lorton and Yvonne Tran, CAO Jenny Herman, and insiders Robert Abel, Karen Akinsanya) executed small-to-moderate sales (roughly 600–1,366 shares each around $12.80–$12.91), collectively reducing insider holdings and contributing to downward pressure. Sample Insider Filing (Robert Abel)
- Negative Sentiment: Multiple filings show these sales occurred within a short window (Mar 4–6), which magnifies market reaction compared with isolated, scheduled sales; however, each sale is a small percentage of total insider stakes and could reflect diversification or option/vesting activity rather than a change in corporate outlook. SEC Filings
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on SDGR shares. TD Cowen restated a “buy” rating on shares of Schrodinger in a report on Thursday, January 8th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Schrodinger in a research note on Friday, January 9th. Wall Street Zen upgraded shares of Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Bank of America raised shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price objective on the stock in a research note on Monday, December 15th. Finally, UBS Group started coverage on shares of Schrodinger in a report on Wednesday, January 7th. They set a “neutral” rating and a $18.00 price objective for the company. Four equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Schrodinger presently has a consensus rating of “Hold” and an average price target of $21.75.
Get Our Latest Research Report on Schrodinger
About Schrodinger
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
Recommended Stories
- Five stocks we like better than Schrodinger
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
